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Abstract
Background: Esophagus squamous cell cancer (ESCC) is the most common cancer in women with
20.2% and second in men with 10.7% relative frequency among all cancer cases diagnosed in Van
Region in the east of Turkey. Ninety percent of all esophageal cancer cases are ESCC and 20–30%
of them have family history of esophageal cancer. The most clear defined hereditary predisposition
associated with ESCC is palmoplantar keratoderma (PPK). To examine the relationship between
ESCC and PPK, we have carried out this case control study.
Methods: The case group consisted of 48 subjects who had new diagnosis of ESCC and did not
receive any chemo or radiotherapy. The control group consisted of 96 healthy individuals who
were visitors of their relatives in the hospital. Two control persons who matched for age, gender,
living place (urban /rural) and region were selected for each case. All subjects were evaluated for
PPK by dermatologist. Evaluation was graded as none, mild, evident and severe. None and mild
subjects were classified as negative for PPK; and others as positive. Relationship between ESCC and
PPK was evaluated with odds ratios and confidence intervals for cases with or without family
history of ESCC.
Results: The PPK frequencies were 92.3% in ESCC cases with family history, 62.5% in ESCC cases
without family history, 70.8% in all ESCC cases, and 28.1% in the control group. Odds ratios for
cases with or without family history of esophageal cancer, and for the whole case group were found
as 30.7 (95%CI = 3.8–247.4), 4.3 (95%CI = 1.9–9.8) and 6.2 (95%CI = 2.9–13.3) respectively.
Conclusion:  Presence of PPK lesions represents genetic susceptibility for ESCC. This
susceptibility for ESCC is the highest among those who have PPK lesions and a positive family
history of esophageal cancer. Furthermore, a PPK sufferer has an increased risk of developing
ESCC even if there is no family history of esophageal cancer.
Background
Esophageal cancer is the eighth most common cancer and
the sixth most common cause of cancer-related mortality
in the world [1]. Esophagus cancer is not a common type
of cancer in Turkey but it remains as a frequently diag-
nosed type in Van region in the east of Turkey [2,3].
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Esophagus cancer is the most common cancer among
women with a proportion of 20.2% and the second most
common cancer among men with a proportion of 10.7%
among all diagnosed cancer cases in Van region [3]. His-
tologically, approximately 90% of esophagus cancer cases
in the region are squamous cell carcinoma.
The Van region, which is located around the Van lake in
the east of Turkey has a population around 2 million peo-
ple which were settled mostly in rural areas (Figure 1).
A series of case control studies from the regions where
ESCC is frequent indicate that smoking, alcohol con-
sumption, hot foods and beverages, and insufficient
intake of fruits and vegetables are significant risk factors
for ESCC [4,5]. The same factors except alcohol consump-
tion has been identified as risk factors in two previous
studies in Van region [6,7]. In addition to these environ-
mental-acquired factors, hereditary – familial risk factors
for ESCC has been described. The most clear hereditary
predisposition syndrome associated with ESCC is tylosis.
Tylosis is a hereditary autosomal dominant syndrome.
The most common sign of this syndrome is palmoplantar
keratoderma (PPK), which develops in pressure-exposed
areas of cutis [8]. PPK is an abnormal thickening and cal-
lusing of the palms and soles due to abnormal keratinisa-
tion [9]. Additionaly, oral leukoplakia and esophageal
hyperkeratosis may accompany to palmoplantar kerato-
derma. Association between tylosis and ESCC was clearly
proven in three good-defined pedigrees [10-12]. In these
families, the risk of developing ESCC among individuals
who had PPK was reported as 40–90% until the age of 70
years; and the risk of developing ESCC was very high com-
pared to the family members who had no PPK within the
same family. Although familial aggregation in ESCC was
reported in a variety of studies in the literature [13-15], it
is not known whether the frequency of PPK in ESCC cases
is high in comparison to healthy individuals. According to
our observations, 20–30% of ESCC patients have a family
history of esophageal cancer in their relatives.
We designed this case control study to examine the hered-
itary predisposition in ESCC, by determining the PPK
frequency among ESCC cases with or without family his-
tory of esophageal cancer in comparison with the control
group including healthy individuals.
The Van region is located around Van Lake in the east of Turkey Figure 1
The Van region is located around Van Lake in the east of Turkey.BMC Cancer 2005, 5:90 http://www.biomedcentral.com/1471-2407/5/90
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Methods
This study was conducted between December 2003 and
December 2004 in the Yuzuncu Yil University Medical
School Hospital. We designed the case control study to
investigate the proportions of PPK lesions among ESCC
patients in comparison to healthy individuals.
The case group consisted of 48 subjects who had new
diagnosis of ESCC. ESCC diagnosis was done by endo-
scopic biopsy. Patients who received any previous chemo
or radiotherapy program were not included in the case
group because of probability that chemo and radiother-
apy could interfere cell dividing kinetics of the epidermis
and could suppress keratoderma. Three ESCC cases were
also excluded because they had striking and intensive
tinea pedis associated to PPK. Two subgroups of the case
group were identified according to their family history of
esophageal carcinoma. The cases who have at least one
additional esophagus cancer case among their first degree
relatives were accepted as family history positive ESCC
cases, and the rest of the group was accepted as family his-
tory negative ESCC cases.
The control group consisted of 96 healthy individuals
who were selected among the visitors of patients hospital-
ized at the departments of internal medicine in the
Yuzuncu Yil University Medical School Hospital. At first,
the visitors who were randomly selected at the inpatient
clinics were interviewed by an introductory questionnaire.
Then, those who have no diagnosed cancer and no close
relative having esophageal or gastric cancer were accepted
to be eligible for the control group.
The control group was matched for age group, gender, liv-
ing place (urban /rural) and region of birth (Van region or
else). For each person in the case group, two persons who
match for age, gender, living place and region of birth
were selected among the eligible persons for the control
group. We intended to decrease the random error by
selecting two controls for each case, instead of one by one
matching. Consequently, the control group was precisely
matched with the case group for the criteria that might
influence the probability of having PPK.
Clinical examination of the cases and the controls were
done by consulting a dermatologist to identify PPK
lesions. Oral leukoplakia, which is a rare finding of tylo-
sis, was not investigated. Palmoplantar lesions were
graded as no PPK, mild PPK, evident PPK and severe PPK.
Those who have no or mild PPK lesions were classified as
PPK negative, and those who have evident or severe PPK
lesions were classified as PPK positive. According to the
type of PPK and the involved area, PPK positive subjects
were further classified as diffuse or focal and palmar,
plantar or palmoplantar PPK.
Statistical analysis was performed with the SPSS (11.5)
software. Odds ratio, 95% confidence interval (CI) of the
odds ratio, and chi-square statistics were calculated for the
whole case group, and the subgroups in comparison to
the controls. The type and localization of PPK lesions in
the case and the control groups were compared with chi-
square statistics.
Results
The distribution of the cases and the controls according to
the matching criteria and the clinical characteristics of the
ESCC cases are shown in table 1.
Table 2 presents the comparison of the case and control
groups according to the proportions of PPK positive sub-
jects. In the case group, the frequency of PPK positive sub-
jects was 70.8% while it was 28.1% in the control group.
The odds ratio of accompanying PPK to ESCC was calcu-
lated as 6.2 (95%CI = 2.9 – 13.3), and the difference
between the proportions of PPK in the case and control
groups was highly significant (p < 0.001).
Table 2 also presents the comparisons between the sub-
groups of cases and the controls. The prevalence of PPK
were 92.3% in ESCC cases with family history, and 62.5%
in ESCC cases without family history. In all comparisons,
the association between PPK and ESCC was statistically
significant. The odds ratio of having PPK for the cases with
Table 1: The general characteristics of cases and controls
Characteristics Case group
(n = 48)
Control group
(n = 96)
Age
Mean (± sd) 50.7 (± 12.0) 49.8 (± 11.5)
Range 25 – 72 24 – 75
Sex
Female 30 (62.5%) 60 (62.5%)
Male 18 (37.5%) 36 (37.5%)
The living place
Rural 27 (56.3%) 54 (56.3%)
Urban 21 (43.8%) 42 (43.8%)
The region of birth
Van region 48 (100%) 96 (100%)
Other 0 0
Stage in time of admission
Localized 17 (35.4%)
Locally-advanced 23 (47.9%)
Metastatic 8 (16.7%)
Histological type
SCC 48 (100%)
Adenocarcinoma 0
SCC: Squamous cell carcinomaBMC Cancer 2005, 5:90 http://www.biomedcentral.com/1471-2407/5/90
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family history was found noticeably high (OR = 30.7;
95%CI = 3.8–247.4).
Table 3 presents the type and localization of PPK lesions
in the case and control groups. In both groups, the type of
PPK lesions was mostly diffuse and the localization was
plantar. Although the proportion of focal and palmar
lesions was higher in the control group compared to the
cases; the difference between two groups was not statisti-
cally significant by chi-square statistics (p > 0.05).
Discussion
Our results showed a significant relationship between
PPK and ESCC. The relationship is particularly high for
ESCC cases with family history of esophageal cancer. As
presented in Table 2, the proportion of PPK is higher in
the ESCC group (70.7%) compared with the control
group (28.1%) with OR = 6.2 (95%CI = 2.9–13.3). The
proportion of PPK is strikingly high in cases with positive
family history (92.3%).
The association of PPK with ESCC was firstly reported by
Clarke and McConnel in one family in 1954 [16]. Then,
this association was confirmed by Howel-Evans et al [10].
In their study of two related Liverpool families, esopha-
geal carcinoma occurred in 18 of 48 tylotic family mem-
bers, but only in one of 87 non-tylotic members. Later,
Ellis et al. reviewed these two related families and por-
trayed a single family containing 345 individuals, 92 were
diagnosed as having focal PPK of which 32 died, 21 of
esophageal cancer [17]. In this pedigree, there was no
oesophageal cancer in family members who were unaf-
fected by PPK. It was calculated that a PPK sufferer in this
pedigree had a 92% probability of dying from oesopha-
Table 2: Comparison of the case and the control groups according to PPKa lesions
Group PPK Positive
n % OR (95%CI) p
All Cases (n = 48)b 34 70.8 6.2 (2.9–13.3) <0.0001
Controls (n = 96) 27 28.1
Cases with FHc(n = 13) 12 92.3 30.7 (3.8–247.4) <0.0001
Controls (n = 96) 27 28.1
Cases without FHd (n = 32) 20 62.5 4.3 (1.9–9.8) <0.0001
Controls (n = 96) 27 28.1
Cases with FH (n = 13) 12 92.3 7.2 (0.83–62.6) 0.046
Cases without FH (n = 32) 20 62.5
a : Palmoplantar keratoderma
b: Because family history of three cases were missing, sum of cases with and without FH is not equal to all cases
c: Cases who have at least one esophagus cancer case among their first degree relatives
d: Cases who have no history of esophagus cancer among their first degree relatives
Table 3: The type and localization of PPKa lesions in the case and the control groups
Characteristics of PPK Cases with PPK (n = 34) Controls with PPK (n = 27)
n%n%
Pattern of keratoderma
Diffuse 32 94.1 21 77.8
Focal 2 5.9 6 22.2
Involved area
Palmar 0 0 2 7.4
Plantar 27 79.4 15 55.6
Palmoplantar 7 20.6 10 37.0
a : Palmoplantar keratodermaBMC Cancer 2005, 5:90 http://www.biomedcentral.com/1471-2407/5/90
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geal cancer by age of 70 [17]. Subsequently, a large mid-
western American pedigree containing 125 affected
individuals with an identical pattern of PPK was
described, in which the skin disorder was associated with
oesophageal and other cancer [11]. In American pedigree,
there were 19 reported malignancies in members with
PPK, eight of which were esophageal or oral squamous
cell carcinomas. The life time risk of developing oesopha-
geal cancer for an affected member of this family was cal-
culated to be 40% by age 70. Maillefer and Greydanus
reported that late-onset PPK lesions (Type A) have a sig-
nificant association with ESCC, while early onset PPK
lesions (Type B) have no such association [18].
We suggest that, the underlying reason of the significant
association between ESCC and PPK in our study is a
hereditary predisposition which causes both PPK lesions
and ESCC. While there is evidence that late onset PPK
might be a paraneoplastic finding for some other types of
cancer [19-21], our observations do not confirm such
explanation for the association between PPK and ESCC.
In these studies [19-21], PPK lesions were found to be
paraneoplastic findings because these lesions were
regressed and disappeared if the cancer was treated and
response was achieved. In our study, we observed some
cases that, there was no change regarding the PPK lesions
after esophageal cancer symptoms regressed and disap-
peared following surgery and primary curative chemora-
diotherapy. Although we do not have reliable data on the
onset of PPK lesions in most ESCC patients, a few of them
exactly remembered that PPK lesions occurred 15–20
years before ESCC symptoms. Maillefer and Greydanus
reported that the onset of type A tylosis occur between the
ages of 5–15 years, while the onset of esophageal cancer
occur no less than the age of 29 years. Therefore, we sug-
gest that PPK lesions do not develop as a result of ESCC
development; rather, ESCC and PPK develop on the same
hereditary background.
PPK may also be caused by environmental reasons and
lifestyle [22]. Although we did not matched the two
groups for the occupation, we controlled the effects of age,
gender and living place (urban / rural). Eighty-eight per-
cent of both groups consisted of men living in rural areas
and women in rural and urban areas. Another survey con-
ducted in Van region showed that almost all women
(98%) in Van were housewives [23]; thus, we may suggest
that women in the case and control groups have similar
lifestyles. Almost all men who live in rural areas work in
farming and breeding; so, they have also very similar life-
styles both in the case and control groups. Thus, we
assume that there is no considerable lifestyle difference
between cases and controls.
The proportion of PPK among the ESCC cases without
family history (62.5%) was also significantly higher than
that of controls (28.1%); and the odds ratio was 4.3
(95%CI = 1.9–9.8). In other words, presence of PPK can
make up risk for ESCC in future even if family history of
ESCC is not present. To explain this result, we need to
look at the genetic background of PPK and ESCC. The sus-
pected gene for PPK and ESCC couldn't be isolated exactly
until now. However, the locus for focal PPK in association
with ESCC has been mapped on chromosome 17q25.
This gene region frequently undergoes to deletion in
hereditary as well as in sporadic ESCC cases [24,25]. The
loss of heterozygosity on 17q25 was detected in 71% and
69% of sporadic ESCC cases. Therefore, it was proven that
this chromosomal region is also commonly affected in
sporadic ESCC cases. The reason why we observed PPK
also in ESCC cases without family history may depend on
the affected same gene locus.
Even though the lowest proportion of PPK in our study
was in the control group, it is still a considerably high pro-
portion (28.1%) compared to some other studies. In their
review on PPK, Maillefer and Greydanus described PPK as
a rare syndrome [18]. The prevalence of PPK in a region of
Sweden, where PPK is frequently observed, has been
reported to be 0.3–0.55% by two studies [26,27]. We may
consider the high proportion of PPK in our control group
as a sign of high PPK prevalence in Van region. One rea-
son of this high prevalence may be work styles that
involve a lot of standing/walking which is highly preva-
lent in both the rural and urban areas in Van region.
Another reason may be the genetic characteristics of the
people. We noted above that all of our ESCC cases and
controls were people whose places of birth were Van
region. Due to a series of social and economical reasons,
people living in this region frequently migrate to other
regions of Turkey; but there is almost no migration from
other regions of Turkey to Van region. Traditionally, most
of the marriages in the local communities happen
between relatives, and a part of these marriages happen
between cousins. Consequently, the region has a homoge-
neous genetic population to a degree and therefore,
hereditary syndromes can be frequently observed in the
local community as in hereditary PPK cases. These charac-
teristics, perhaps, made Van region a suitable place to
observe such association between ESCC and PPK.
The study contains some limitations that should be noted.
Firstly, sizes of the case and control groups are not large.
This could lead to a type II error if there was not a big dif-
ference between the proportions in the case and control
groups. In our study, the small group sizes did not lead to
insignificant results, but this caused some large confi-
dence intervals as seen in table 2. Secondly, our data on
the association between PPK and ESCC is based on aBMC Cancer 2005, 5:90 http://www.biomedcentral.com/1471-2407/5/90
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matched case control design; rather than longitudinal.
This limits the extent to which conclusions about causal-
ity can be drawn. Thirdly, we did not investigate the
genetic inheritance of the PPK in relatives of ESCC
patients and controls; thus, we are not able to discuss the
existence of a dominant inheritance pattern for PPK. This
point should be a focus of future research.
Conclusion
We suggest that presence of PPK lesions represents genetic
susceptibility for ESCC. This susceptibility for ESCC is
highest among those who have PPK lesions and a positive
family history of esophageal cancer. Furthermore, a PPK
sufferer has an increased risk of developing ESCC even if
there is no family history of esophageal cancer. This result
provides additional evidence on the genetic background
of PPK and ESCC.
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